Okay here we go. Another week of projections, ano

Okay here we go. Another week of projections, another week of waiting for news from Mr. Schneiderman, another week of "are we or are not in the cloud", another week of charts, and another week of the Hangout cheerleading SCRC, and another week of the possibility SCRC remains at the .10 - .11 P/S level.

Well, I say BRING IT ON!!! As I have stated several times in the past, I was told when I first purchased SCRC that Q1 & Q2 of 2014 was the time frame for SCRC's success to begin. As far as I can see, we are right on target. Yes, there has been a shift in the revenue emphasis from RapiMeds to Compounding Pharmacy. Both are still important to the bottom line but through the business brilliance of Mr. Schneiderman, SCRC has created a cash flow positive, revenue producing business on track to becoming a $12 - $24M dollar a year company. SCRC's business model of diversity is the key to future success. Yes, compounding is the focal point right now and rightly so, the $$$ potential is incredible and uncapped. However, I personally don't care where the revenues come from, I just want SCRC to be successful. And successful it will become.. It was exciting to read Bsav's projections, not because of the thorough analysis, but because I believed in everything that was presented.

So yes, I am still positive and will remain so. SCRC is building huge momentum and will soon be noticed by the investment world. SCRC is on the verge of greatness and we will all be there to enjoy it's success.